跳至主要内容
临床试验/ACTRN12610000671066
ACTRN12610000671066尚未招募不适用

Fenofibrate effects on endothelial progenitor cell (EPC) number and function in patients with recent diagnosis of type 2 diabetes mellitus (T2DM).

Prof Anthony Keech0 个研究点目标入组 22 人开始时间: 2010年8月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1)Recently diagnosed type 2 diabetes mellitus in adults.
  • 2) No previous recent exposure to or any current definite indication for statins or fibrates

排除标准

  • 1) Age less than 18 years
  • 2) Pregnant women(based on urine Beta Human Choriogonadotrophin test (HCG))
  • 3) Cognitively impaired, homeless people or others considered unlikely to comply.
  • 4) Acute myocardial infarction within the last 3 months
  • 5) Anemia with Hemoglobin < 110 mg/dl
  • 6) Significant renal impairment (estimated Glomerular Filtration Rate<60 ml/min/1.73m^2)
  • 7) Active liver disease
  • 8) Clinical gallbladder disease
  • 9)Known hypersensitivity to statin or fibrate therapy
  • 10) Severe hypertriglyceridaemia and/or pancreatitis requiring fibrate therapy

研究者

发起方
Prof Anthony Keech

相似试验